Enhancing the Value of Choice for Clinical Management of Uterine Fibroids Through Shared Decision-Making

This activity is part of a series


Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Professor and Vice Chair for Research
Department of Obstetrics and Gynecology, University of Chicago
Gynecologist and Endoscopic Surgeon, UC Medical Center
Chicago, IL
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP

Dr. Ayman Al-Hendy is currently a tenured professor and Vice Chair of Research in the Department of Obstetrics and Gynecology, as well as advisor to the Dean of Medicine at Pritzker School of Medicine, University of Chicago (UC). Dr. Al-Hendy is a gynecologist and endoscopic surgeon at UC Medical Center in Chicago, Illinois with a busy practice that focuses on serving women with symptomatic uterine fibroids and premature ovarian insufficiency. Dr. Al-Hendy is double board certified by the Royal College of Surgeons of Canada and The American Board of Obstetrics and Gynecology. Dr. Al-Hendy’s medical research interests focus on developing novel therapies, including gene and stem cell therapy, for premature ovarian insufficiency, endometriosis, and particularly uterine fibroids. Dr. Al-Hendy has published more than 242 peer-reviewed publications in high-tier scientific journals, participated in more than 360 presentations in national and international meetings, and edited 5 medical books. Dr. Al-Hendy has also been elected as the 71st President of the Society for Reproductive Investigation.

Nisha McKenzie, PA-C, CSC, NCMP, IF
CEO and Founder, Women's+ Health Collective
Grand Rapids Charter Township, MI
Nisha McKenzie, PA-C, CSC, NCMP, IF

Nisha McKenzie is the founder and owner of the Women’s+ Health Collective in Grand Rapids, MI. She graduated in 2002 with a master’s in medicine – Physician Assistant studies. Since that time, she has dedicated her career to women’s health, sexual health, hormones, and survivorship. Beginning in 2011, she intently focused on women’s sexual health and its relation to overall health. She completed the University of Michigan Sexual Health Certificate Program in cohort 2014. She is a Nationally Certified Menopause Practitioner and a Fellow of the International Society for the Study of Women’s Sexual Health. Nisha teaches both sexual medicine and gynecology for the Grand Valley State University PA Program and the Western Michigan University PA Program. She also regularly precepts PA, NP, and medical students as well as licensed medical professionals. She speaks at medical and therapy conferences across the country with a dedication to helping providers understand how to better include sexual health into general health as well as how to break down gender bias in medicine.

Tanika Gray Valbrun
Founder and CEO, The White Dress Project
Atlanta, GA
Tanika Gray Valbrun

Tanika Gray Valbrun is an award-winning journalist, educator, and non-profit founder with a passion for women’s health. After her personal struggles with uterine fibroids, including two myomectomies, Tanika’s passion for women’s health inspired her to create The White Dress Project, a non-profit organization dedicated to providing support for women suffering from fibroids and to raise awareness through fibroid education. As the founder of The White Dress Project, Tanika has successfully worked with doctors, health advocates, and elected officials across the country to get legislation passed declaring July as “Fibroids Awareness Month.” Recognized as a thought leader and patient advocate for uterine health, she has also spoken around the world encouraging women to be their own best health advocate. Many women with symptomatic fibroids never dream of wearing white because of their heavy menstrual bleeding or bloating. The white dress is a “symbol of hope” that women with fibroids can feel supported and know that they do not have to suffer in silence. In addition to encouraging women to be their own health advocates, Tanika works as a senior content producer for a global news organization where she has been awarded three coveted Peabody Awards for her contributions in journalism.

Statement of Need

Similar to many gynecologic conditions, there is stigma and embarrassment associated with the symptoms of uterine fibroids, and seeking treatment can be difficult. This difficulty is compounded when racial and ethnic discrimination and health care disparities are taken into account. It is imperative that clinicians, both specialist and primary care, effectively utilize shared decision-making (SDM) to explore the impact of the treatments they select for patients with uterine fibroids. Plan development should focus on long-term considerations, including fertility, sexual health, disease management, financial impact, mental wellness, quality of life, racial/ethnic disparities, and mitigating risk factors/potential side effects.

In the final activity of this CME Outfitters Snack series, expert faculty will help learners to identify opportunities to integrate effective and inclusive SDM into their clinical practice and implement patient-centered treatment plans for patients with uterine fibroids.

Learning Objective

Utilize SDM to develop patient-centered treatment plans for patients with uterine fibroids.

Financial Support

Supported by an educational grant from Pfizer Inc. and Sumitomo Pharma America.

Target Audience

Obstetrician-gynecologists, primary care physicians, nurse practitioners (NPs), physician associates (PAs), and nurses.

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Interprofessional (IPCE) 0.75

This activity was planned by and for the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education (IPCE) Credit for learning and change.

Physicians (ACCME) 0.75

CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. CME Outfitters, LLC, designates this enduring activity for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 0.75

This activity is designated for 0.75 contact hour. Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)™ from Jointly Accredited Organizations. Nurse practitioners can also apply for credit through their state boards.

Note for California Nurses

This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.

PAs (AAPA) 0.75

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until expiration date listed above. PAs should only claim credit commensurate with the extent of their participation.


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.

Dr. Al-Hendy reports the following financial relationships:

Consultant: AbbVie Inc.; Bayer; Myovant Sciences; Norvartis Pharmaceuticals Corporation; ObsEva; and Pfizer Inc.

Research Support: CrilaHealth

Ms. McKenzie reports the following financial relationships:

Consultant: Agile Therapeutics; Palatin; and Pfizer Inc.

Speakers Bureau: Astellas Pharma Inc. and Bayer.

Ms. Valbrun reports the following financial relationships:

Consultant: Myovant Sciences/Pfizer Inc.

Grants: (Paid to The White Dress Project) Ferring Pharmaceuticals; Gynesonics; Hologic, Inc.; and Myovant Sciences/Pfizer Inc.

Speakers Bureau: Myovant Sciences/Pfizer Inc.

Disclosures were obtained from the Outfitters, LLC staff; no disclosures to report:

  • Joshua Caballero, PharmD, BCPP, FCCP (peer reviewer)
  • Morgan Stockberger, MD (planning committee)
  • Jessica Whelan, DNP, APRN, FPMHNP-BC, RN-BC (planning committee)
  • Susan H. Yarbrough, CHCP (planning committee)
  • Sandra Caballero, PharmD (planning committee)
  • Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).


Enhancing the Value of Choice for Clinical Management of Uterine Fibroids Through Shared Decision-Making
Event Date: 08/25/2023